Transgenomic Q2 net sales climb

Transgenomic’s net loss was $6m, compared to $1.15m for the same period in the prior year.

The company’s loss from operations was $1.62m for the second quarter ended 30 June 2011, compared to $1.06m for the same period in 2010.

For the six months ended 30 June 2011 net sales were $15.15m, compared to $10.54m for the same period in 2010.

Net loss was $8.78m for the six months ended 30 June 2011, as compared to $1.47m for the same period prior year.

For the six months ended 30 June 2011, the company’s loss from operations were $2.37m, as compared to $1.43m for the same period in 2010.